Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00108290 · ClinicalTrials.gov registry record · Phase 2
Chemotherapy, Hormone Therapy, and Surgery to Remove the Prostate Gland in Patients With High Risk Prostate Cancer
A Phase 2 study, sponsored by US Department of Veterans Affairs.
- Completed
- Registry status
- Phase 2
- Development phase
NCT00108290 is a Phase 2 study that has completed, run by US Department of Veterans Affairs.
The verdict
NCT00108290, a Phase 2 study, has completed, sponsored by US Department of Veterans Affairs.
- COMPLETED
- Registry status
- Phase 2
- Development phase
Study Summary
In men with prostate cancer who do not have evidence of spread to bone or other sites on computed axial tomography (CAT) scan/bone scan but are still at significant risk of failing treatment with surgery or radiation alone, a combination of chemotherapy and hormone therapy is being given for 6 months followed by surgery to remove the prostate.
Interventions
- DRUG Chemotherapy
Trial Details
| Field | Value |
|---|---|
| Start Date | 2004-04 |
| Est. Completion | 2007-03 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00108290
The ClinicalTrials.gov registry entry for NCT00108290 describes a study currently listed as completed, categorized as Phase 2. An enrollment target was not published in the registry record, which is common for early-stage or observational entries. The listed sponsor is US Department of Veterans Affairs, which has 632 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Chemotherapy is the first listed.
NCT00108290 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00108290 about?
NCT00108290 is a clinical study titled "Chemotherapy, Hormone Therapy, and Surgery to Remove the Prostate Gland in Patients With High Risk Prostate Cancer". In men with prostate cancer who do not have evidence of spread to bone or other sites on computed axial tomography (CAT) scan/bone scan but are still at significant risk of failing treatment with surgery or radiation alone, a combination of chemotherapy and hormone therapy is being given for 6 month...
What is the current status of trial NCT00108290?
This trial is currently completed. It is a Phase 2 study. The study started on 2004-04. Estimated completion is 2007-03.
What interventions are being tested in trial NCT00108290?
The interventions under investigation include: Chemotherapy (DRUG).
Who is sponsoring clinical trial NCT00108290?
This trial is sponsored by US Department of Veterans Affairs, which has 632 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.